Hiscox Ltd (LON:HSX – Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,633.60 and traded as high as GBX 1,834. Hiscox shares last traded at GBX 1,816, with a volume of 803,878 shares.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on HSX. JPMorgan Chase & Co. boosted their price target on Hiscox from GBX 1,800 to GBX 2,050 and gave the company an “overweight” rating in a research note on Friday, July 10th. Berenberg Bank increased their price objective on Hiscox from GBX 1,760 to GBX 1,900 and gave the stock a “buy” rating in a research report on Friday, May 8th. Royal Bank Of Canada reissued an “outperform” rating and set a GBX 1,850 target price on shares of Hiscox in a report on Wednesday, June 24th. Peel Hunt reissued an “add” rating and issued a GBX 1,960 target price on shares of Hiscox in a research report on Thursday, May 28th. Finally, Jefferies Financial Group restated an “underperform” rating and issued a GBX 1,148 price target on shares of Hiscox in a research note on Thursday, May 7th. Five research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of GBX 1,770.17.
View Our Latest Stock Report on HSX
Hiscox Stock Down 0.4%
About Hiscox
Hiscox is a global, specialty insurer, listed on the London Stock Exchange and headquartered in Bermuda. We have grown from
our roots as a niche Lloyd’s of London underwriter into a diversified international insurance group operating across direct‑to‑consumer, broker and partner‑distributed retail insurance; large and complex commercial insurance; reinsurance and insurance‑linked strategies.
We currently employ over 3,000 people worldwide across 13 countries and 31 offices. We have a distinctive brand, energised and ambitious teams, a strong balance sheet, and plenty of room to grow in each of our chosen markets and lines of business.
Read More
- Five stocks we like better than Hiscox
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
- MarketBeat Week in Review – 07/27- 07/31
Receive News & Ratings for Hiscox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hiscox and related companies with MarketBeat.com's FREE daily email newsletter.
